CN104940887A - Application of drug combination - Google Patents

Application of drug combination Download PDF

Info

Publication number
CN104940887A
CN104940887A CN201510426216.9A CN201510426216A CN104940887A CN 104940887 A CN104940887 A CN 104940887A CN 201510426216 A CN201510426216 A CN 201510426216A CN 104940887 A CN104940887 A CN 104940887A
Authority
CN
China
Prior art keywords
parts
application
medicine
pharmaceutical composition
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510426216.9A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510426216.9A priority Critical patent/CN104940887A/en
Publication of CN104940887A publication Critical patent/CN104940887A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to new application of a drug combination in the field of pharmacy, and belongs to the technical field of traditional Chinese medicine, wherein the drug combination includes curcuma longa, coral ginger and other ingredients The drug combination comprises 50 parts of curcuma longa, 50 parts of paris, 50 parts of perfoliate knotweed, 25 parts of chenopodium ambrosioides, 25 parts of goldenrod, 25 parts of rba gynostemae and 50 parts of the coral ginger. The drug combination has the functions of relieving acute soft tissue contusion swelling and improving pathological changes of tissue and can be used for treating traumatic injuries as well as tenosynovitis, lumbar disc herniation, hyperosteogeny and pruritus caused by medical diseases.

Description

A kind of purposes of pharmaceutical composition
Technical field
The present invention is a kind of purposes of pharmaceutical composition, belongs to the technical field of Chinese medicine.
Background technology
Eliminating acne turmeric liniment is OTC (over-the-counter) class liniment, and main component is Rhizoma Curcumae Longae, Rhizoma Paridis, Herba Polygoni cymosi, Herba Solidaginis, Herba Chenopodii, Herb Gynostemmae Pentaphylli, Rhizoma Zingiberis corallini, for the acne (acne) caused by damp and hot strongly fragrant skin.The preparation method of existing product is as follows: get Rhizoma Curcumae Longae, Rhizoma Zingiberis corallini is ground into coarse powder, and vapor distillation extracts volatile oil, for subsequent use.Herb Gynostemmae Pentaphylli, Herba Solidaginis, Rhizoma Paridis are ground into fine powder, carry out percolation according to the percolation (Chinese Pharmacopoeia version in 2000 annex I O) under fluid extract and extractum item with 6 times amount 80% ethanol as solvent, collect liquid of filtering, for subsequent use.Get Herba Polygoni cymosi, Herba Chenopodii, decoct with water three times, 2 hours first times, second time 1.5 hours, 1 hour third time, collecting decoction, filter, it is 1.18 ~ 1.22(60 DEG C that filtrate is concentrated into relative density) clear paste, add ethanol and reach 50% to alcohol content, leave standstill 24 hours and filter, filtrate and above-mentioned liquid of filtering merge.Separately getting after volatile oil adds polyoxyethylene sorbitan monoleate emulsifying adds in above-mentioned medicinal liquid, mixing, filters, is adjusted to ormal weight, obtains final product.
Summary of the invention
The object of the present invention is to provide the novelty teabag of this Chinese patent medicine, the new opplication namely in pharmacy.
In fact, the present invention relates to activated feedstock be Rhizoma Curcumae Longae, Rhizoma Paridis, Herba Polygoni cymosi, Herba Solidaginis, Herba Chenopodii, Herb Gynostemmae Pentaphylli, Rhizoma Zingiberis corallini pharmaceutical composition as preparation treatment traumatic injury medicine in application.
Relate to this pharmaceutical composition as the application in the medicine of preparation treatment tenosynovitis.
Relate to this pharmaceutical composition as the application in the medicine of preparation treatment prolapse of lumbar intervertebral disc.
Relate to this pharmaceutical composition as the application in the medicine of preparation treatment hyperosteogeny.
Relate to the application in the medicine of the pruritus that this pharmaceutical composition causes as preparation treatment internal disease.
The internal disease of the described pruritus that often occurs together has: chronic kidney hypofunction, cholestasis, gestation, polycythemia vera, anemia, hyperthyroidism, diabetes, multiple sclerosis, psychological psychosis, tumor, systemic parasitic disease, drug eruption, sjogren syndrome, HIV (human immunodeficiency virus) (HIV) infect.
Pharmacodynamic experiment result shows, this pharmaceutical composition has analgesia, alleviates the effect of acute soft tissue contusion swelling, and improve the pathological change of tissue, show as subcutaneous tissue and muscle tissue damage alleviates, neutrophil infiltrates reduces, tissue repair is very fast.Can be used for treating traumatic injury, tenosynovitis.
Pharmacodynamic experiment result shows, this pharmaceutical composition can improve microcirculation, slow down the effect of nerve root injury, has good therapeutic effect to the lumbago and skelalgia symptom that prolapse of lumbar intervertebral disc causes.
Pharmacodynamic experiment result also shows, this pharmaceutical composition can improve the blood viscosity of dextran acid anhydride blood stasis rabbit, Rat Tall Flick reaction caused by Carrageenan swollen feet, cott on pellet-induced granuloma formation and photo-thermal all has remarkable inhibitory action, can be used for treating hyperosteogeny.
Pharmacodynamic experiment result also shows, this pharmaceutical composition can suppress the isolated ileum segments in guinea pigs smooth muscle anaphylaxis caused by ovalbumin (OA) to be shunk; The mast cell granule that remarkable suppression OA causes; Significantly can suppress the lymphocytic conversion of T in Freund's complete adjuvant sensitized rats blood.The foot swelling that can significantly suppress OA to cause, and reduce the content of PGE in inflammatory tissue; Excite dermatitis skin lesion to be that tissue has obvious therapeutic action to OA sensitization, and reduce the content of IL-2 in delayed hypersensitivity tissue caused by Freund's complete adjuvant; The Mice licking response that remarkable suppression 4-aminopyridine brings out., can be used for the pruritus that treatment internal disease causes.
Comprehensive above-mentioned experimental result, can draw and the invention has the advantages that:
(1) the present invention has excavated new medical application to known Chinese patent medicine eliminating acne turmeric liniment, has opened up new application.
(2) product of the present invention can be prepared into the external preparation such as liniment, gel, Emulsion, spray.
concrete embodiment
Embodiment 1: get Rhizoma Curcumae Longae, Rhizoma Zingiberis corallini is ground into coarse powder, vapor distillation extracts volatile oil, for subsequent use.Herb Gynostemmae Pentaphylli, Herba Solidaginis, Rhizoma Paridis are ground into fine powder, carry out percolation according to the percolation (Chinese Pharmacopoeia version in 2000 annex I O) under fluid extract and extractum item with 6 times amount 80% ethanol as solvent, collect liquid of filtering, for subsequent use.Get Herba Polygoni cymosi, Herba Chenopodii, decoct with water three times, 2 hours first times, second time 1.5 hours, 1 hour third time, collecting decoction, filter, it is 1.18 ~ 1.22(60 DEG C that filtrate is concentrated into relative density) clear paste, add ethanol and reach 50% to alcohol content, leave standstill 24 hours and filter, filtrate and above-mentioned liquid of filtering merge.Separately getting after volatile oil adds polyoxyethylene sorbitan monoleate emulsifying adds in above-mentioned medicinal liquid, mixing, filters, is adjusted to ormal weight, obtains liniment.
Usage and dosage: external.Medicine is applied to affected part, outer wiping every day 2-3 time.
Embodiment 2: Rhizoma Curcumae Longae 50g, Rhizoma Paridis 50g, Herba Polygoni cymosi 50g, Herba Chenopodii 25g, Herba Solidaginis 25g, Herb Gynostemmae Pentaphylli 25g, Rhizoma Zingiberis corallini 50g, gets Rhizoma Curcumae Longae, Rhizoma Zingiberis corallini is ground into coarse powder, and vapor distillation extracts volatile oil, adds appropriate propylene glycol and dissolves rear for subsequent use.Herb Gynostemmae Pentaphylli, Herba Solidaginis, Rhizoma Paridis are ground into fine powder, carry out percolation according to the percolation (Chinese Pharmacopoeia version in 2000 annex I O) under fluid extract and extractum item with 6 times amount 80% ethanol as solvent, collect liquid of filtering, for subsequent use.Get Herba Polygoni cymosi, Herba Chenopodii, decoct with water three times, 2 hours first times, second time 1.5 hours, 1 hour third time, collecting decoction, filter, it is 1.18 ~ 1.22(60 DEG C that filtrate is concentrated into relative density) clear paste, add ethanol and reach 50% to alcohol content, leave standstill 24 hours and filter, filtrate and above-mentioned liquid of filtering merge.Reclaiming ethanol to relative density is 1.04 ~ 1.06(60 DEG C) for subsequent use.Get stearic acid 100g, lanoline 50g, paraffin 100g, liquid paraffin 80ml mix homogeneously, be heated to 85 DEG C, stirring adds above-mentioned medicinal liquid after dissolving, mix and blend 20 minutes, stop heating, treat that temperature of charge is reduced to less than 40 DEG C, add the propylene glycol solution of above-mentioned volatile oil, stir and obtain ointment.
Usage and dosage: external.Ointment is applied to affected part, outer wiping every day 2-3 time.
Embodiment 3: Rhizoma Curcumae Longae 50g, Rhizoma Paridis 50g, Herba Polygoni cymosi 50g, Herba Chenopodii 25g, Herba Solidaginis 25g, Herb Gynostemmae Pentaphylli 25g, Rhizoma Zingiberis corallini 50g, gets Rhizoma Curcumae Longae, Rhizoma Zingiberis corallini is ground into coarse powder, and vapor distillation extracts volatile oil, for subsequent use after adding appropriate dissolve with ethanol.Herb Gynostemmae Pentaphylli, Herba Solidaginis, Rhizoma Paridis are ground into fine powder, carry out percolation according to the percolation (Chinese Pharmacopoeia version in 2000 annex I O) under fluid extract and extractum item with 6 times amount 80% ethanol as solvent, collect liquid of filtering, for subsequent use.Get Herba Polygoni cymosi, Herba Chenopodii, decoct with water three times, 2 hours first times, second time 1.5 hours, 1 hour third time, collecting decoction, filter, it is 1.18 ~ 1.22(60 DEG C that filtrate is concentrated into relative density) clear paste, add ethanol and reach 50% to alcohol content, leave standstill 24 hours filter, the alcoholic solution of filtrate and above-mentioned filter liquid and volatile oil merges, mix homogeneously, is dispensed in pressure vessel, pours compressed nitrogen and namely obtains spray.
Usage and dosage: external.Medicine is sprayed at affected part, outer wiping every day 2-3 time.
Embodiment 4: Rhizoma Curcumae Longae 50g, Rhizoma Paridis 50g, Herba Polygoni cymosi 50g, Herba Chenopodii 25g, Herba Solidaginis 25g, Herb Gynostemmae Pentaphylli 25g, Rhizoma Zingiberis corallini 50g, gets Rhizoma Curcumae Longae, Rhizoma Zingiberis corallini is ground into coarse powder, and vapor distillation extracts volatile oil, for subsequent use after adding appropriate dissolve with ethanol.Herb Gynostemmae Pentaphylli, Herba Solidaginis, Rhizoma Paridis are ground into fine powder, carry out percolation according to the percolation (Chinese Pharmacopoeia version in 2000 annex I O) under fluid extract and extractum item with 6 times amount 80% ethanol as solvent, collect liquid of filtering, for subsequent use.Get Herba Polygoni cymosi, Herba Chenopodii, decoct with water three times, 2 hours first times, second time 1.5 hours, 1 hour third time, collecting decoction, filter, it is 1.18 ~ 1.22(60 DEG C that filtrate is concentrated into relative density) clear paste, add ethanol and reach 50% to alcohol content, leave standstill 24 hours and filter, the alcoholic solution of filtrate and above-mentioned filter liquid and volatile oil merges, mix homogeneously, decompression recycling ethanol to relative density ρ=1.05 ~ 1.08(60 DEG C), add 2 times of water to stir, add the 940 type carbomers of 1% again, stir 1 hour, add the propylene glycol solution of volatile oil again, homogenizing 30 minutes, pH=6 ~ 7 are regulated with triethanolamine, homogenizing 30 minutes again, obtain gel.

Claims (6)

1. the application of following pharmaceutical composition in the medicine of preparation treatment traumatic injury:
50 parts, Rhizoma Curcumae Longae, Rhizoma Paridis 50 parts, Herba Polygoni cymosi 50 parts, Herba Chenopodii 25 parts, Herba Solidaginis 25 parts, Herb Gynostemmae Pentaphylli 25 parts, Rhizoma Zingiberis corallini 50 parts
Above-mentioned number is weight portion.
2. the application of pharmaceutical composition according to claim 1 in the medicine of preparation treatment tenosynovitis.
3. the application of pharmaceutical composition according to claim 1 in the medicine of preparation treatment hyperosteogeny.
4. the application of pharmaceutical composition according to claim 1 in the medicine of preparation treatment prolapse of lumbar intervertebral disc.
5. pharmaceutical composition according to claim 1 treats the application in the medicine of the pruritus that internal disease causes in preparation.
6. application according to claim 5, wherein internal disease comprises chronic kidney hypofunction, cholestasis, gestation, polycythemia vera, anemia, hyperthyroidism, diabetes, multiple sclerosis, psychological psychosis, tumor, systemic parasitic disease, drug eruption, sjogren syndrome, HIV (human immunodeficiency virus) infection.
CN201510426216.9A 2015-07-20 2015-07-20 Application of drug combination Pending CN104940887A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510426216.9A CN104940887A (en) 2015-07-20 2015-07-20 Application of drug combination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510426216.9A CN104940887A (en) 2015-07-20 2015-07-20 Application of drug combination

Publications (1)

Publication Number Publication Date
CN104940887A true CN104940887A (en) 2015-09-30

Family

ID=54156310

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510426216.9A Pending CN104940887A (en) 2015-07-20 2015-07-20 Application of drug combination

Country Status (1)

Country Link
CN (1) CN104940887A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114159352A (en) * 2021-12-16 2022-03-11 广州温雅日用化妆品有限公司 Bacteriostatic and itching-relieving foam shampoo
CN118001366A (en) * 2024-01-31 2024-05-10 明远药业有限公司 Special medicine for treating acne and acnes in puberty and preparation process thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895632A (en) * 2006-06-15 2007-01-17 贵阳舒美达制药厂有限公司 Compound turmeric acne-eliminating gel and its preparation
CN101524509A (en) * 2008-03-07 2009-09-09 大连永兴生物医药孵化器有限公司 Curcuma acne eliminating gel paste for treating acne

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1895632A (en) * 2006-06-15 2007-01-17 贵阳舒美达制药厂有限公司 Compound turmeric acne-eliminating gel and its preparation
CN101524509A (en) * 2008-03-07 2009-09-09 大连永兴生物医药孵化器有限公司 Curcuma acne eliminating gel paste for treating acne

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
陈嬝嬝等: "姜黄消痤搽剂对大、小鼠炎症组织的抗炎作用", 《中国实验方剂学杂志》 *
陈嬝嬝等: "姜黄消痤搽剂抗过敏及止痒作用的实验研究", 《现代中医药》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114159352A (en) * 2021-12-16 2022-03-11 广州温雅日用化妆品有限公司 Bacteriostatic and itching-relieving foam shampoo
CN114159352B (en) * 2021-12-16 2024-06-28 广州温雅日用化妆品有限公司 Foam shampoo with antibacterial and antipruritic effects
CN118001366A (en) * 2024-01-31 2024-05-10 明远药业有限公司 Special medicine for treating acne and acnes in puberty and preparation process thereof
CN118001366B (en) * 2024-01-31 2025-08-15 明远药业有限公司 Special medicine for treating acne and acnes in puberty and preparation process thereof

Similar Documents

Publication Publication Date Title
CN100462097C (en) Externally applied ointment for treating hyperosteogeny and preparation method thereof
CN101618186B (en) Traditional Chinese medicine prescription for treating arthritis
CN104940887A (en) Application of drug combination
CN104225466A (en) Traditional Chinese medicinal composition used for lowering blood lipid
CN106266949A (en) A kind of compound Chinese medicinal preparation and its preparation method and application
CN107693750A (en) A kind of method that anti-prostatic hyperplasia material is extracted from turmeric
CN104606628A (en) Face-nourishing, beautifying and chloasma-removing traditional Chinese medicine composition
CN103751307B (en) A kind of external application analgesic Chinese patent medicine and preparation technology thereof
CN102670852A (en) Spraying agent for resisting inflammatory and relieving pains as well as preparation method and application of spraying agent
CN106421630A (en) Radix Curcumae Aromaticae extract product, and preparation method and application thereof
CN1116892C (en) Bagged blood circulation-activating and obstruction-dredging granule and its preparation
CN100431598C (en) A traditional Chinese medicine plaster for treating asthma and preparation method thereof
CN1899316B (en) Chinese medicine micro emulsion preparation and its preparing method
CN102727542A (en) Ointment with function of relieving swelling and pain
CN104740570B (en) Medicine acted on dispelling wind and eliminating dampness and swelling and pain relieving and its production and use
CN112716931B (en) External pharmaceutical composition for improving thyroid nodule
CN108057105A (en) It is a kind of for vegetable oil composition of the auxiliary treatment proliferation of mammary gland and preparation method thereof
CN102085255A (en) Medicinal composition with functions of promoting blood circulation and freeing channels as well as dispelling wind and relieving pain and preparation method thereof
CN1238047C (en) Ointment for stopping arthralgia and formula
CN113081972A (en) Preparation method of radix angelicae pubescentis and parasitic loranthus granules
CN104000905B (en) A kind of Chinese medicine for jaundice in pregnancy patient's pruritus vulvae and preparation method thereof
CN105535519A (en) Preparation method of compound rhizoma corydalis film coating agent for local pain relieving
CN118576685A (en) A preparation method of Gutongling tincture
CN101991731A (en) Oral administration medicine composition for treating female sterility
CN104225550A (en) Preparation method for blood-activating and pain-stopping paste

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150930

WD01 Invention patent application deemed withdrawn after publication